ICER #WeeklyView: LPAR webinar & more on health care affordability conta.cc/3WTqglD
TODAY -- join ICER at 11 AM ET for a virtual public meeting to discuss treatments for #hypertension.
Register here:events.zoom.us/ev/AiBr45RLxk…
ICYMI -- ICER hosted a #webinar on Oct 27th to discuss this year's ICER/@WestHealth Launch Price and Access report.
Watch the webinar: youtu.be/gXnbeb6ocUs
Read the report: icer.org/news-insights/press…
#LaunchPricing #PrescriptionDrugs #FairAccess #PatientAffordability
TODAY -- Join us for a #webinar to discuss the 2026 Launch Price and Access Report findings. Register here: shorturl.at/MdkFd
#patientaccess #affordability #evidencebased #prescriptiondrugs #valuebased @WestHealth
Oct 27th, join us for a #webinar to discuss the 2026 Launch Price and Access Report findings.
Register here: shorturl.at/MdkFd
#patientaccess #affordability #evidencebased #prescriptiondrugs #valuebased
@WestHealth
The HEMA Draft Report public comment period ends Nov 2. Submit your public comments now! @NICEComms @CDA_AMC
The Health Economics Methods Advisory (#HEMA) today released a Draft Report on how HTA bodies can evaluate, present, and communicate uncertainty in #healtheconomic evaluations. #hta #populationhealth
Now accepting public comments until Nov 2. Read more: shorturl.at/mOe0F
ICER #WeeklyView: 2026 Launch Price and Access report, a psilocybin review, & more on health care spending conta.cc/3WFFSZT
This week, ICER and West Health released our 2026 Launch Price and Access Report.
There will be a public webinar on October 27, 2026 to discuss to discuss the report findings and the implications for affordability and patient access.
Register Here: events.zoom.us/ev/Asv-bJSL0L…
On October 29th, join ICER for a virtual public meeting to discuss treatments for #hypertension.
Register here: events.zoom.us/ev/AiBr45RLxk…
Institute for Clinical and Economic Review to Assess Therapy for Treatment-Resistant Depression: icer.org/wp-content/uploads/…
ICER and @WestHealth released a new “Launch Price and Access Report,” finding that the median drug launch prices continue to exceed $250,000 per year, contributing to increases in overall healthcare costs. Read more: shorturl.at/qAL1J
#DrugPricing #PatientAccess #RxPricing
ICER retweeted
"You're going to get government intervention, and it's going to be crappy." -- @icer_review's Sarah Emond at the @statnews Summit on what will happen if the healthcare system doesn't adopt a voluntary, value-focused approach to prices.
Many thanks to @statnews for inviting ICER's President and CEO Sarah Emond to speak as a panelist alongside @NPLB_org Priscilla VanderVeer at this year's #STATSummit!
When moderator ed silverman asked for one short-term solution to address the drug pricing problem in the US, Sarah highlighted the importance of tying drug price to value.
ICER #WeeklyView: an ICER Webinar, Draft Report, & Covid vax for pregnant women conta.cc/4s69s6s
Today, ICER released a Draft Evidence Report assessing the comparative clinical effectiveness and value of two new treatments for Friedreich’s Ataxia, a #rare, #genetic disorder: tinyurl.com/ycy8fb67
This draft is now open to public comments until November 11th.
On Oct 20, ICER and @WestHealth are releasing our 2026 Launch Price and Access Report.
On Oct 27th, join us for a #webinar to discuss the report findings. Register here: shorturl.at/MdkFd
#patientaccess #affordability #evidencebased #prescriptiondrugs #valuebased
ICER #WeeklyView: HEMA Draft Report, an ICER webinar, & impact of Rx prices on employers conta.cc/4rSUj8F
On Oct 20, ICER and @WestHealth are releasing our 2026 Launch Price and Access Report.
On Oct 27th, join us for a #webinar to discuss the report findings. Register here: shorturl.at/MdkFd
#patientaccess #affordability #evidencebased #prescriptiondrugs #valuebased







